Creo Medical’s €24.8 Million Acquisition Of Albyn Medical

Osborne Clarke has advised Creo Medical Group plc on the acquisition of Albyn Medical for an equity value of €24.8m. The agreement also included a performance-related…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Paolo Bossi

This content is for Standard 1 Year members only.
Login Join Now